Grantsmanship Resources & Grants of Interest to the CBST Community See more grant listings on BiophotonicsWorldGrantsmanship Resources (Source: http://writedit.wordpress.com/)
Grants of Interest to the CBST CommunityNSF Grant Opportunities for Academic Liaison with Industry (GOALI)http://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf09516 Full Proposal Deadline(s): Proposals Accepted Anytime. Check with the program officer in the specific field of the proposed research for acceptable submission periods. Synopsis of Program: Grant Opportunities for Academic Liaison with Industry (GOALI) promotes university-industry partnerships by making project funds or fellowships/traineeships available to support an eclectic mix of industry-university linkages. Special interest is focused on affording the opportunity for:
This solicitation targets high-risk/high-gain research with a focus on fundamental research, new approaches to solving generic problems, development of innovative collaborative industry-university educational programs, and direct transfer of new knowledge between academe and industry. GOALI seeks to fund transformative research that lies beyond that which industry would normally fund. National Science Foundation, Innovations in Engineering Education, Curriculum and Infrastructure Deadline: 2010-01-20; 2010-03-30Department of Health and Human Services, National Institutes of Health LOI deadlines: 2010-01-23, 2010-04-27, 2010-08-30 Application deadlines: 2010-02-23, 2010-05-27, 2010-09-30 Purpose: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications that propose exploratory research projects on the initial application of emerging analytical technologies as laboratory or clinical tools. An “emerging technology” is defined as one that has passed the initial developmental stage, but has not yet been evaluated within the context of its intended use. Projects proposed in response to this FOA should have the potential to produce a major impact in a broad area of cancer-relevant research. If successful, these technologies would accelerate research in cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. This FOA solicits R21 applications that have high potential impact and allows for an element of technical risk; preliminary data are not required. All projects must include quantitative milestones (i.e. technical metrics that determine whether the specific aims have been accomplished). Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this solicitation and will be returned as non-responsive. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. Department of Health and Human Services, National Institutes of Health LOI deadline: 2010-01-23, 2010-04-27, 2010-08-2010 Application deadline: 2010-02-23, 2010-05-27, 2010-09-30 Purpose: This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing technically innovative feasibility studies focused on early stage development of cancer-relevant technologies. If successful, these technologies would accelerate the research and understanding of basic cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. This FOA solicits R21 applications and is suitable for projects at their inception, conceptual or idea based, where technical feasibility of the proposed technology or methodology has not yet been established. The R21 mechanism requires high potential impact and allows for an element of technical risk; projects proposed in response to this FOA may reflect this level of risk but must have concurrent potential to produce a major impact in a broad area of cancer-relevant research. All projects must include quantitative milestones (i.e. technical metrics that determine whether the specific aims have been accomplished). Projects proposing to use technology that is already established or projects where the novelty resides in the biological or clinical question being pursued are examples of topics not appropriate for this solicitation and will be returned as non-responsive. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. NIH/NCI Validation and Advanced Development of Emerging Technologies LOI deadline: 2010-01-23, 2010-04-27, 2010-08-30 Application deadline: 2010-02-23, 2010-05-27, 2010-09-30 Purpose: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing research projects on the advanced development of emerging molecular and cellular analysis technologies through technical/analytical validation in an appropriate cancer-relevant biological system. An “emerging technology” is defined as one that has passed the pilot developmental stage and shows promise, but has not yet been evaluated within the context of its intended use. If successful, these technologies would accelerate research in cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. This FOA solicits R33 applications; this mechanism is suitable for projects where “proof-of-principle” of the proposed technology or methodology has been established and supportive preliminary data are available. Projects proposed to this FOA should reflect the potential to produce a major impact in a broad area of cancer-relevant research. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this solicitation and will be returned as non-responsive. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. Department of Health and Human Services, National Institutes of Health German Academic Exchange Service (DAAD)-Pro, German Academic Exchange Service (DAAD), Research Project Grant (Parent R01) Deadline: 2010-02-05; 2010-06-05; 2010-10-05Department of Health and Human Services, National Institutes of Health Bioengineering Research Grants (BRG)(R01) Deadline: 2010-02-05; 2010-06-05; 2010-10-05Department of Health and Human Services. National Institutes of Health NIH Exploratory Developmental Research Grant Program (Parent R21) The National Institutes of Health (NIH) Exploratory/Developmental Grant (R21) funding opportunity supports the development of new research activities in categorical program areas. (Support generally is restricted in level of support and in time.) Investigator-initiated research, also known as unsolicited research, is research funded as a result of an investigator submitting a research grant application to NIH in an investigators area of interest and competency. All investigator-initiated exploratory/developmental applications described in this announcement will be assigned to NIH institutes and centers (ICs) according to standard Public Health Service referral guidelines and specific program interests. Investigators are strongly encouraged to consult the list of participating ICs and special research interests. The Exploratory/Developmental Grant (R21) mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. This funding opportunity announcement will use the NIH Exploratory/Developmental (R21) award mechanism. The total project period for an application submitted in response to this funding opportunity may not exceed 2 years. Direct costs are limited to $275,000 over an R21 2-year period, with no more than $200,000 in direct costs allowed in any single year. Deadline: 2010-02-16; 2010-06-16; 2010-10-16DARPA Centers in Integrated Photonics Engineering Research (CIPhER) Deadline: Feb 19, 2010 Purpose: DARPA is soliciting innovative proposals for university research centers in the area of integrated photonics engineering. Proposed research should investigate innovative approaches that enable revolutionary advances in science, devices, or systems. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice. National Science Foundation Biosensing Program Application submission window: Feb 1, 2010 - Mar 3, 2010 Purpose: The Biosensing Program supports innovative, transformative, and insightful investigations of fundamental problems with broad long term impact and applications that require novel use of bio-inspired engineering principles and sophisticated devices to meet the engineering and technology needs of the nation. The program is targeting research in the area of the monitoring, identification, and/or quantification of biological phenomena and will support potential technological breakthroughs that exist at the intersection of engineering, life science, and information technology. Projects submitted to the Program must advance both engineering and life sciences.Projects in the program may range from single investigator to multi-investigator collaborative research efforts. The development of these novel principles and devices will require highly collaborative interactions between engineers, life scientists, and experts in nanotechnology, biomaterials, bioinformatics, and the chemical and physical sciences. The program recognizes the important role of education and workforce development specifically relevant to the multidisciplinary nature of the area of biosensing. Interdisciplinary teams are essential and must be fostered from discovery to application. NSF Biophotonics, Advanced Imaging, and Sensing for Human Health Modification 2 Application submission window: Feb 1, 2010 - Mar 3, 2010 Purpose: Innovative basic research in photonics, imaging, and sensing that is very fundamental in science and engineering is needed to lay the foundation for new technologies beyond those that are mature and ready for application in medical diagnostics and therapies. Developing molecularly specific sensing (molecular photonics), imaging, and monitoring systems with high sensitivity and resolution would be an enormous accomplishment with powerful applications to both biology and medicine. Low cost diagnostics will require novel integration of photonics, molecular biology, and material science. Complex biosensors capable of detecting and discriminating among large classes of biomolecules could be important not only to biology and medicine, but also to environmental sensing and homeland security. The BISH program supports innovative research of biophotonic, imaging, and sensing technologies for applications in human health. NSF Biomedical Engineering Application submission window: Feb 1, 2010 - Mar 3, 2010 Purpose: The mission of the Biomedical Engineering (BME) Program is to
The BME program supports fundamental, transformative, and discovery research applied to biological systems. National Science Foundation. Pan-American Advanced Studies Institutes Program http://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf10517 The Pan-American Advanced Studies Institutes (PASI) Program is a jointly supported initiative between the Department of Energy and the National Science Foundation (NSF). Pan-American Advanced Studies Institutes are short courses ranging in length from 10 days to one month, involving lectures, demonstrations, research seminars, and discussions at the advanced graduate, postdoctoral, and junior faculty level. PASIs aim to disseminate advanced scientific and engineering knowledge and stimulate training and cooperation among researchers of the Americas in the mathematical, physical, and biological sciences, the geosciences, the computer and information sciences, and the engineering fields. Proposals in other areas funded by NSF may be considered on an ad hoc basis; in this case, lead investigators must consult with the PASI program before proposal submission. Whenever feasible, an interdisciplinary approach is recommended. The estimated number of awards is 10 to 16. The anticipated funding amount is $1.2 million, pending the availability of funds. Deadline: 2010-03-19NIH Shared Instrumentation Grant Program (S10) Application deadline: March 23, 2010. No Letter of Intent necessary. Purpose. The NCRR Shared Instrument Grant (SIG) program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instrumentation or an integrated system that costs at least $100,000. The maximum award is $600,000. Types of instruments supported include confocal and electron microscopes, biomedical imagers, mass spectrometers, DNA sequencers, biosensors, cell sorters, X-ray diffraction systems, and NMR spectrometers among others. Mechanism of Support. This funding opportunity will use the NIH S10 mechanism. Funds Available and Anticipated Number of Awards. The NCRR intends to commit approximately $43 million in FY2011 to fund approximately 125 new awards. Since the cost of the various instruments will vary, it is anticipated that the size of awards will also vary. The total amount awarded and the number of awards will depend on the funds available for the SIG program. NSF/FDA SCHOLAR-IN-RESIDENCE AT FDAFull Proposal Deadline Date: April 27, 2010 http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5605&org=CISE&from=home Synopsis The National Science Foundation (NSF), through the Directorate for Engineering's Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET), and the U.S. Food and Drug Administration (FDA), through its Center for Devices and Radiological Health (CDRH) have established the NSF/FDA Scholar-in-Residence Program at FDA. This program comprises an interagency partnership for the investigation of scientific and engineering issues concerning emerging trends in medical device technology. This partnership is designed to enable investigators in science, engineering, and mathematics to develop research collaborations within the intramural research environment at the FDA. This solicitation features four flexible mechanisms for support of research at the FDA: 1) Faculty at FDA; 2) Graduate Student Fellowships; 3) Postdoctoral Fellowships; and, 4) Undergraduate Student Research Experiences. Undergraduate student participants supported with NSF funds must be citizens or permanent residents of the United States. HHS, NIH: In vivo Cellular and Molecular Imaging Centers (ICMICs) (P50) Grant LOI deadline: 2010-09-28, 2011-09-28 Application deadline: 2010-10-28, 2011-10-28 Purpose: The program will fund the 5-year P50 ICMIC grants to support interdisciplinary scientific teams conducting cutting-edge cancer molecular imaging research. ICMIC funding is designed to: (1) support innovative cancer molecular imaging research projects; (2) support unique core facilities; (3) enable the awardees to initiate pilot research in new promising directions; and (4) provide interdisciplinary career development opportunities for investigators new to the field of molecular cancer imaging. |
|
|
|
|
|